<VariationArchive VariationID="214046" VariationName="NM_020247.5(COQ8A):c.1844dup (p.Ser616fs)" VariationType="Duplication" Accession="VCV000214046" Version="12" RecordType="classified" NumberOfSubmissions="6" NumberOfSubmitters="6" DateLastUpdated="2024-06-23" DateCreated="2015-10-11" MostRecentSubmission="2023-11-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="210644" VariationID="214046">
      <GeneList>
        <Gene Symbol="COQ8A" FullName="coenzyme Q8A" GeneID="56997" HGNC_ID="HGNC:16812" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q42.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="226940294" stop="226987544" display_start="226940294" display_stop="226987544" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="227127937" stop="227175245" display_start="227127937" display_stop="227175245" Strand="+" />
          </Location>
          <OMIM>606980</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_020247.5(COQ8A):c.1844dup (p.Ser616fs)</Name>
      <CanonicalSPDI>NC_000001.11:226986631:GGGGGG:GGGGGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>1q42.13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="226986631" stop="226986632" display_start="226986631" display_stop="226986632" variantLength="1" positionVCF="226986631" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="227174332" stop="227174333" display_start="227174332" display_stop="227174333" variantLength="1" positionVCF="227174332" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
      </Location>
      <OtherNameList>
        <Name>1844_1845insG</Name>
      </OtherNameList>
      <ProteinChange>S616fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.227174338dup" Assembly="GRCh37">
            <Expression>NC_000001.10:g.227174338dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.226986637dup" Assembly="GRCh38">
            <Expression>NC_000001.11:g.226986637dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012825.2" sequenceAccession="NG_012825" sequenceVersion="2" change="g.94102dup">
            <Expression>NG_012825.2:g.94102dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020247.5" sequenceAccession="NM_020247" sequenceVersion="5" change="c.1844dup" MANESelect="true">
            <Expression>NM_020247.5:c.1844dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_064632.2" sequenceAccession="NP_064632" sequenceVersion="2" change="p.Ser616fs">
            <Expression>NP_064632.2:p.Ser616fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1092" sequenceAccession="LRG_1092">
            <Expression>LRG_1092:g.94102dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1092t1" sequenceAccession="LRG_1092t1">
            <Expression>LRG_1092t1:c.1844dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1092p1" sequenceAccession="LRG_1092p1" change="p.Ser616fs">
            <Expression>LRG_1092p1:p.Ser616fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020247.4" sequenceAccession="NM_020247" sequenceVersion="4" change="c.1844dupG">
            <Expression>NM_020247.4:c.1844dupG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020247.5" sequenceAccession="NM_020247" sequenceVersion="5" change="c.1844dupG" MANESelect="true">
            <Expression>NM_020247.5:c.1844dupG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA320338" DB="ClinGen" />
        <XRef Type="rs" ID="764847439" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_020247.5(COQ8A):c.1844dup (p.Ser616fs) AND not provided" Accession="RCV000195954" Version="7">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-07-06" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_020247.5(COQ8A):c.1844dup (p.Ser616fs) AND Autosomal recessive ataxia due to ubiquinone deficiency" Accession="RCV000416393" Version="3">
        <ClassifiedConditionList TraitSetID="956">
          <ClassifiedCondition DB="MedGen" ID="C2677589">Autosomal recessive ataxia due to ubiquinone deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-10-06" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_020247.5(COQ8A):c.1844dup (p.Ser616fs) AND ADCK3-related disorder" Accession="RCV000778224" Version="5">
        <ClassifiedConditionList TraitSetID="47281">
          <ClassifiedCondition>ADCK3-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-10-30" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-10-06" NumberOfSubmissions="6" NumberOfSubmitters="6" DateCreated="2015-10-11" MostRecentSubmission="2023-11-20">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(4); Uncertain significance(1)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">24218524</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32743982</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32961396</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">34663476</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">28125198</ID>
          <ID Source="BookShelf">NBK410087</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(4); Uncertain significance(1)</Comment>
        <DescriptionHistory Dated="2019-05-24">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="47281" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="41672" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">ADCK3-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ADCK3-Related Disorders</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="956" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5960" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Spinocerebellar ataxia, autosomal recessive 9</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Coenzyme Q10 deficiency, primary, 4</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive ataxia due to ubiquinone deficiency</ElementValue>
                <XRef ID="MONDO:0012784" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SCAR9</ElementValue>
                <XRef Type="MIM" ID="612016" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">COQ10D4</ElementValue>
                <XRef Type="MIM" ID="612016" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Primary coenzyme Q10 (CoQ10) deficiency is usually associated with multisystem involvement, including neurologic manifestations such as fatal neonatal encephalopathy with hypotonia; a late-onset slowly progressive multiple-system atrophy-like phenotype (neurodegeneration with autonomic failure and various combinations of parkinsonism and cerebellar ataxia, and pyramidal dysfunction); and dystonia, spasticity, seizures, and intellectual disability. Steroid-resistant nephrotic syndrome (SRNS), the hallmark renal manifestation, is often the initial manifestation either as isolated renal involvement that progresses to end-stage renal disease (ESRD), or associated with encephalopathy (seizures, stroke-like episodes, severe neurologic impairment) resulting in early death. Hypertrophic cardiomyopathy (HCM), retinopathy or optic atrophy, and sensorineural hearing loss can also be seen.</Attribute>
                <XRef ID="NBK410087" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10294" />
                <XRef ID="10294" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">28125198</ID>
                <ID Source="BookShelf">NBK410087</ID>
              </Citation>
              <XRef ID="139485" DB="Orphanet" />
              <XRef ID="C2677589" DB="MedGen" />
              <XRef ID="MONDO:0012784" DB="MONDO" />
              <XRef Type="MIM" ID="612016" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1195902" SubmissionDate="2017-08-17" DateLastUpdated="2015-10-11" DateCreated="2015-10-11">
        <ClinVarSubmissionID localKey="NM_020247.4:c.1844dup|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000612251" DateUpdated="2015-10-11" DateCreated="2015-10-11" Type="SCV" Version="1" SubmitterName="Athena Diagnostics" OrgID="1012" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-02-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24218524</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Athena Diagnostics Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">26467025</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ADCK3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.Ser616Leufs*114</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_020247.4:c.1844dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB2963629</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="466165" SubmissionDate="2019-01-29" DateLastUpdated="2019-04-17" DateCreated="2015-10-11">
        <ClinVarSubmissionID localKey="GDX:2162|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000251075" DateUpdated="2019-04-17" DateCreated="2015-10-11" Type="SCV" Version="4" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-01-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.1844dupG variant in the ADCK3 gene causes a frameshift starting with codon Serine 616, changes this amino acid to a Leucine residue and creates a premature Stop codon at position 114 of the new reading frame, denoted p.Ser616LeufsX114. This mutation is predicted to cause loss of normal protein function by resulting in the replacement of the last 32 amino acids of the ADCK3 protein by 113 incorrect amino acids, which is predicted to affect the secondary structure and function of the ADCK3 protein. Although this variant has not been previously reported to our knowledge, it is expected to be a pathogenic variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COQ8A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="1" alternateAllele="GG" referenceAllele="G" start="227174338" stop="227174339" variantLength="2" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_020247.4:c.1844dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="966448" SubmissionDate="2016-06-07" DateLastUpdated="2022-10-01" DateCreated="2017-02-02">
        <ClinVarSubmissionID localKey="NM_020247.4:c.1844dupG|OMIM:612016" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV000494107" DateUpdated="2022-10-01" DateCreated="2017-02-02" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="BookShelf">NBK410087</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COQ8A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NP_064632.2:p.Ser616LeufsTer114</Name>
            <Name>1844_1845insG</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_020247.4:c.1844dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2677589" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11808016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1789457" SubmissionDate="2019-02-01" DateLastUpdated="2019-05-27" DateCreated="2019-05-27">
        <ClinVarSubmissionID localKey="666830" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000914392" DateUpdated="2019-05-27" DateCreated="2019-05-27" Type="SCV" Version="1" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-10-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24218524</ID>
          </Citation>
          <Comment>The ADCK3 c.1844dupG (p.Ser616LeufsTer114) variant results in a frameshift, and is predicted to cause an elongation of the protein. This variant is located in the last exon of the gene and may escape nonsense-mediated decay. The p.Ser616LeufsTer114 variant has been reported in one study in which it was identified in a homozygous state in two affected siblings with an adolescence onset of cerebellar ataxia and severe myoclonus from a consanguineous Pakistani family (Liu et al. 2014). Patient fibroblasts from the proband showed significantly reduced levels of coenzyme Q10 (CoQ10) and reduced activity of mitochondrial complex I and complexes IIÎ“Ã‡Ã´III compared to controls. Furthermore, the symptoms of the proband improved upon treatment with CoQ10. Control data are unavailable for this variant, which is reported at a frequency of 0.0003180 in the East Asian population of the Genome Aggregation Database. Based on the limited evidence and potential impact of frameshift variants, the ADCK3 p.Ser616LeufsTer114 variant is classified as a variant of unknown significance but suspicious for pathogenicity for an autosomal recessive form of spinocerebellar ataxia associated with primary coenzyme Q10 deficiency. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification Criteria 09 May 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/thsgk7t4/icsl_variant_classification_criteria_09_may_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ADCK3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="1" alternateAllele="TG" referenceAllele="T" start="227174332" stop="227174332" variantLength="1" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_020247.4:c.1844dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ADCK3-Related Disorders</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5118208</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4150273" SubmissionDate="2023-01-06" DateLastUpdated="2023-02-07" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="4825074|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002134137" DateUpdated="2023-02-07" DateCreated="2022-03-28" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-07-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24218524</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32743982</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32961396</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">34663476</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24218524</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ser616Leufs*114) in the COQ8A gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 32 amino acid(s) of the COQ8A protein. This variant is present in population databases (rs761498232, gnomAD 0.03%). This premature translational stop signal has been observed in individuals with clinical features of coenzyme Q10 deficiency (PMID: 24218524, 32743982, 32961396, 34663476). ClinVar contains an entry for this variant (Variation ID: 214046). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this premature translational stop signal affects COQ8A function (PMID: 24218524). This variant disrupts a region of the COQ8A protein in which other variant(s) (p.Arg626His) have been observed in individuals with COQ8A-related conditions (Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COQ8A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.227174332_227174333insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7702250" SubmissionDate="2023-11-14" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="NM_020247.5:c.1844dupG|MedGen:C2677589" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004122573" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">32961396</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24218524</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32743982</ID>
          </Citation>
          <Comment>Variant summary: CABC1 c.1844dupG (p.Ser616LeufsX114), located within the last exon, causes a frameshift which disrupts the last 32 amino acids of the encoded protein sequence and results in an extension of the protein, but is not predicted to undergo nonsense mediated decay. The variant allele was found at a frequency of 6.7e-05 in 282792 control chromosomes (gnomAD). c.1844dupG has been reported in the literature as a biallelic genotype in multiple individuals affected with Autosomal Recessive Ataxia Due To Ubiquinone Deficiency, including reports where symptoms have improved following CoQ10 supplementation, and has been found to segregate with the disease phenotype in at least one family (e.g. Liu_2014, Jiao_2020, Zhang_2020). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 32961396, 24218524, 32743982). Four submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Three submitters classified the variant as pathogenic, and one classified it as uncertain significance. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COQ8A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_020247.5:c.1844dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2677589" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13972740</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7702250" TraitType="Disease" MappingType="XRef" MappingValue="C2677589" MappingRef="MedGen">
        <MedGen CUI="C2677589" Name="Autosomal recessive ataxia due to ubiquinone deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="466165" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4150273" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1789457" TraitType="Disease" MappingType="Name" MappingValue="ADCK3-Related Disorders" MappingRef="Preferred">
        <MedGen CUI="None" Name="ADCK3-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1195902" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="966448" TraitType="Disease" MappingType="XRef" MappingValue="C2677589" MappingRef="MedGen">
        <MedGen CUI="C2677589" Name="Autosomal recessive ataxia due to ubiquinone deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

